UnitedHealth Group (UNH)
$232.89
0.04 (0.02%)
UNH Stock Quote Delayed 15 Minutes
Previous Close
$232.89
Market Cap
223.80B
PE Ratio
20.50
EPS
11.36
Volume (Avg. Vol.)
6.25M
Day's Range
231.92 - 235.00
52-Week Range
208.07 - 287.94
Dividend & Yield
3.30 (1.42%)
UNH Stock Predictions, Articles, and UnitedHealth Group News
Dow Jones Today: It Could Have Been Worse
In fact, the results for Friday, the last trading day of August, weren't too shabby when considering there was a concerning consumer data point released earlier today. Regular readers know that I've been beating the consumer drum quite a bit recently and it is a story worth following for investors.
3 Big Stock Charts for Wednesday: eBay, UnitedHealth and Berkshire Hathaway
The stock charts of EBAY, UNH and BRK.B have run through the trading wringer in the shadow of the market's stumble.
Dow Jones Today: Not Much Activity, But That’s OK
An interesting fact, courtesy of the ETF Research Center, the price-to-earnings ratio on the SPDR Dow Jones Industrial ETF (NYSEARCA:DIA), the Dow tracking ETF, currently resides in an area that was seen following the fourth-quarter 2018 and May 2019 declines, which eventually gave way to equity market rallies.
Is UnitedHealth Stock’s Dividend Worth the Hassle for Investors?
Uncertainty in the healthcare sector means that for many investors, UNH stock's dividend just isn't worth it.
UnitedHealth Earnings: UNH Stock Dips Despite Q2 Beat
UnitedHealth earnings for the second quarter of 2019 have UNH stock falling, despite the company's positive results for the period.
Dow Jones Today: A Lackluster Showing
In advance of some important earnings reports coming Thursday from some big-name members of the Dow Jones Industrial Average, the major U.S. equity indexes did a whole lot of nothing Wednesday.
3 Big Stock Charts for Friday: HollyFrontier, Activision Blizzard and Vertex Pharmaceuticals
The stock charts of HollyFrontier, Activision Blizzard and Vertex Pharmaceuticals are poised to end the trading week in a pivotal situation.
Dow Jones Today: More Fed Fun, but Healthcare Weakness Caps Gains
While it appears unlikely that the Fed will lower rates by 50 basis points this month, markets are increasingly comfortable with the notion of 0.25% reduction followed by more of the same in September.
Dow Jones Today: Why These Big Names Got Drubbed
Something that has been discussed here in recent days is the shift away from trade concerns to company-specific issues. That was very much the case today as a slew of big names in the Dow were punished for a variety of stock-specific reasons. Let's have a look at some of those names.
Dow Jones Today: Maybe We’re Getting Somewhere
Despite the jitters going into Saturday's G20 meeting, the Dow Jones today was aided by a decent earnings report before the bell from WBA.
3 Healthcare Stocks to Buy With the Market Near All-Time Highs
PFE, JNJ and UNH are three healthcare stocks to buy even up near all-time market highs. Each for its own reasons.
Dow Jones Today: A Typical Summer Friday
Long-term investors can find some solace with an article in Barron's today indicating Dow 30,000 could arrive sooner than expected.
Dow Jones Today: Stocks Almost Had Some Fed Fun
While the Federal Reserve did not cut rates, stocks were still feeling optimistic. Several big names were up in the Dow Jones today.
CVS Stock Has More Going for It Than Just a 3.69% Dividend Yield
A judge is challenging the CVS Health-Aetna deal and the drug store sector is out of favor. So when will the discount on CVS stock end?
Dow Jones Today: Jobs Report Was a Dud, But Stocks Didn’t Mind
Comments from President Trump regarding Mexico potentially avoiding trade tariffs set to go into effect next week were among the catalysts for stocks today. Trump is pushing Mexico to buy more from U.S. farmers, saying that if Mexico cooperates, tariffs could be avoided.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
C
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!
